These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7097455)

  • 21. Drug impurities: problems and regulations.
    Pifferi G; Mannucci A
    Boll Chim Farm; 1999 Nov; 138(10):500-7. PubMed ID: 10765465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 23. Expert systems for parenteral development.
    Rowe RC; Wakerly MG; Roberts RJ; Grundy RU; Upjohn NG
    PDA J Pharm Sci Technol; 1995; 49(5):257-61. PubMed ID: 7489202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of compendial antimicrobial effectiveness tests: a review.
    Moser CL; Meyer BK
    AAPS PharmSciTech; 2011 Mar; 12(1):222-6. PubMed ID: 21221871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elaborate decision criteria for media fill tests.
    Deeks T
    PDA J Pharm Sci Technol; 1995; 49(2):56-7. PubMed ID: 7780744
    [No Abstract]   [Full Text] [Related]  

  • 26. Elaborate decision criteria for media fill tests.
    Prout G
    PDA J Pharm Sci Technol; 1995; 49(2):57-8. PubMed ID: 7632287
    [No Abstract]   [Full Text] [Related]  

  • 27. [Illegal drug trade discovered in Bavaria. How can we protect ourselves from drug falsification?].
    Schweim HG
    MMW Fortschr Med; 2005 Sep; 147(38):11. PubMed ID: 16218221
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recent aspects of the microbiological contamination of pharmaceutical products and their microbiological specification (author's transl)].
    Kurata H; Ishizeki C; Udagawa S
    Eisei Shikenjo Hokoku; 1978; (96):1-26. PubMed ID: 373832
    [No Abstract]   [Full Text] [Related]  

  • 29. Quantitative NMR spectroscopy--applications in drug analysis.
    Holzgrabe U; Deubner R; Schollmayer C; Waibel B
    J Pharm Biomed Anal; 2005 Aug; 38(5):806-12. PubMed ID: 15893899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ASHP guidelines on quality assurance for pharmacy-prepared sterile products. American Society of Health System Pharmacists.
    Am J Health Syst Pharm; 2000 Jun; 57(12):1150-69. PubMed ID: 10911516
    [No Abstract]   [Full Text] [Related]  

  • 31. A model particulate research laboratory: I. Characterization of glass for parenteral products.
    Scothorn WW; Roseman TJ; Hamlin WE
    Bull Parenter Drug Assoc; 1976; 30(3):105-17. PubMed ID: 1268429
    [No Abstract]   [Full Text] [Related]  

  • 32. Panel discussion: international drug regulations and their practical application. I. Swedish experience of drug regulations and their applications.
    Liljestrand A
    Bull Parenter Drug Assoc; 1974; 28(4):153-60. PubMed ID: 4853527
    [No Abstract]   [Full Text] [Related]  

  • 33. Particle contamination of parenteralia and in-line filtration of proteinaceous drugs.
    Werner BP; Winter G
    Int J Pharm; 2015 Dec; 496(2):250-67. PubMed ID: 26556624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The contamination of large volume parenteral solutions by foreign particles. Proposal for updating the Italian regulations].
    Pavanetto F; Montanari L; Conti B; Ponci R
    Farmaco Prat; 1986 Jan; 41(1):3-14. PubMed ID: 3956714
    [No Abstract]   [Full Text] [Related]  

  • 35. Control of low-level microbial contamination of drug preparations.
    Hess H; Knüsel F; Mullen K
    Pharm Acta Helv; 1969 Mar; 44(3):174-91. PubMed ID: 5790044
    [No Abstract]   [Full Text] [Related]  

  • 36. Overview of the forthcoming PDA task force report on the inspection for visible particles in parenteral products: practical answers for present problems.
    Knapp JZ
    PDA J Pharm Sci Technol; 2003; 57(2):131-9. PubMed ID: 14674515
    [No Abstract]   [Full Text] [Related]  

  • 37. Microbiological tests on oral pediatric medicines--requirements for an improved pharmacopoeia monograph.
    Long PF; Han J; Tuleu C; Wong IC
    Ann Pharmacother; 2006 Jan; 40(1):158-9. PubMed ID: 16368921
    [No Abstract]   [Full Text] [Related]  

  • 38. Reply: To PMID 22264942.
    Gonzalez S; Rosenfeld PJ
    Am J Ophthalmol; 2013 Feb; 155(2):410-1. PubMed ID: 23312447
    [No Abstract]   [Full Text] [Related]  

  • 39. Microbial limits reviewed: the basis for unique Australian regulatory requirements for microbial quality of non-sterile pharmaceuticals.
    Tang S
    PDA J Pharm Sci Technol; 1998; 52(3):100-9. PubMed ID: 9691672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Microbiological quality of pharmaceutical products not mandatorily sterilized].
    Tagliapietra L
    Boll Chim Farm; 1978 Jan; 117(1):1-13. PubMed ID: 743347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.